MBL Wealth LLC Has $1.20 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

MBL Wealth LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 2,359 shares of the healthcare conglomerate’s stock after selling 169 shares during the quarter. MBL Wealth LLC’s holdings in UnitedHealth Group were worth $1,201,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. International Assets Investment Management LLC raised its holdings in UnitedHealth Group by 1.9% in the 4th quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock valued at $2,352,000 after buying an additional 85 shares during the last quarter. Tennessee Valley Asset Management Partners bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $158,000. Rakuten Securities Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $153,000. Migdal Insurance & Financial Holdings Ltd. grew its stake in UnitedHealth Group by 181.5% in the fourth quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,467 shares of the healthcare conglomerate’s stock valued at $2,346,000 after acquiring an additional 2,880 shares during the period. Finally, Telos Capital Management Inc. lifted its holdings in shares of UnitedHealth Group by 19.8% in the 4th quarter. Telos Capital Management Inc. now owns 1,601 shares of the healthcare conglomerate’s stock worth $843,000 after purchasing an additional 265 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, July 23rd. Truist Financial upped their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Robert W. Baird upped their target price on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, August 13th. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Trading Down 0.3 %

NYSE:UNH traded down $1.93 during trading hours on Friday, reaching $577.68. The company’s stock had a trading volume of 2,728,939 shares, compared to its average volume of 4,224,914. The firm has a 50-day simple moving average of $529.38 and a 200-day simple moving average of $507.45. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $591.54. The firm has a market capitalization of $533.44 billion, a price-to-earnings ratio of 35.31, a PEG ratio of 1.61 and a beta of 0.59. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.14 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.